Total Payments
$49,798
2021 Payments
$1,755
Companies
6
Transactions
44
Medicare Patients
508
Medicare Billing
$64,810
Payment Breakdown by Category
Consulting$35,108 (70.5%)
Travel$7,192 (14.4%)
Other$6,000 (12.0%)
Food & Beverage$1,499 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,108 | 8 | 70.5% |
| Travel and Lodging | $7,192 | 19 | 14.4% |
| Honoraria | $6,000 | 2 | 12.0% |
| Food and Beverage | $1,499 | 15 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $32,778 | 25 | $0 (2019) |
| H. Lundbeck A S | $8,605 | 8 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $5,246 | 6 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $1,755 | 2 | $0 (2021) |
| Alkermes, Inc. | $1,325 | 2 | $0 (2017) |
| Allergan Inc. | $88.26 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,755 | 2 | ACADIA Pharmaceuticals Inc ($1,755) |
| 2019 | $13,458 | 4 | Otsuka America Pharmaceutical, Inc. ($13,458) |
| 2018 | $9,443 | 20 | Avanir Pharmaceuticals, Inc. ($5,246) |
| 2017 | $25,142 | 18 | Otsuka America Pharmaceutical, Inc. ($15,124) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $35.01 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/30/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $1,720.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/31/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Consulting Fee | Cash or cash equivalent | $13,312.50 | General |
| Category: PSYCHIATRY | ||||||
| 01/22/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Travel and Lodging | Cash or cash equivalent | $108.00 | General |
| Category: PSYCHIATRY | ||||||
| 01/22/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Travel and Lodging | Cash or cash equivalent | $25.66 | General |
| Category: PSYCHIATRY | ||||||
| 01/22/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | Cash or cash equivalent | $11.54 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2018 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $42.76 | General |
| 12/14/2018 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $41.54 | General |
| 12/14/2018 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $13.72 | General |
| 12/13/2018 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | In-kind items and services | $692.76 | General |
| 12/13/2018 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $46.15 | General |
| 12/06/2018 | Avanir Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,250.00 | General |
| 12/06/2018 | Avanir Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $72.00 | General |
| 11/17/2018 | Avanir Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $367.40 | General |
| 11/17/2018 | Avanir Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $241.92 | General |
| 11/17/2018 | Avanir Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $198.57 | General |
| 11/16/2018 | Avanir Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $116.53 | General |
| 08/08/2018 | Otsuka America Pharmaceutical, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 08/08/2018 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $48.75 | General |
| 08/08/2018 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $22.50 | General |
| 08/08/2018 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | Cash or cash equivalent | $3.80 | General |
| 03/23/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/23/2018 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $314.42 | General |
| 03/23/2018 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $222.96 | General |
| 03/23/2018 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $32.20 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 13 | $3,094 | $942.00 |
| 2022 | 1 | 14 | 14 | $700.00 | $262.06 |
| 2021 | 5 | 236 | 486 | $165,313 | $32,027 |
| 2020 | 6 | 245 | 519 | $190,886 | $31,579 |
Total Patients
508
Total Services
1,032
Medicare Billing
$64,810
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $3,094 | $942.00 | 30.4% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 14 | 14 | $700.00 | $262.06 | 37.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 93 | $66,216 | $11,407 | 17.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 73 | $38,179 | $6,409 | 16.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 32 | $28,992 | $5,235 | 18.1% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 91 | 219 | $10,950 | $4,705 | 43.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 39 | 69 | $20,976 | $4,271 | 20.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 61 | 93 | $69,815 | $9,440 | 13.5% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 21 | 84 | $36,566 | $6,782 | 18.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 86 | $53,558 | $5,950 | 11.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 48 | 65 | $19,799 | $4,069 | 20.6% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 76 | 175 | $8,750 | $3,722 | 42.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 16 | $2,398 | $1,615 | 67.3% |
About Dr. Laura Dunn, M.D
Dr. Laura Dunn, M.D is a Psychiatry healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083725394.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Dunn, M.D has received a total of $49,798 in payments from pharmaceutical and medical device companies, with $1,755 received in 2021. These payments were reported across 44 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($35,108).
As a Medicare-enrolled provider, Dunn has provided services to 508 Medicare beneficiaries, totaling 1,032 services with total Medicare billing of $64,810. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Geriatric Psychiatry, Geriatric Psychiatry
- Location Little Rock, AR
- Active Since 08/31/2006
- Last Updated 04/19/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1083725394
Products in Payments
- ABILIFY MYCITE (Drug) $13,833
- REXULTI (Drug) $8,605
- NUPLAZID (Drug) $1,755
- NAMZARIC (Drug) $88.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Little Rock
Dr. Leslie Smith, M.d, M.D
Psychiatry — Payments: $719,166
Psychiatry $719,166
Dr. Tad Tillemans, M.d, M.D
Psychiatry — Payments: $667,044
Psychiatry $667,044
Dr. Gintaras Aukstuolis, Md, MD
Psychiatry — Payments: $49,122
Psychiatry $49,122
Dr. Margaret Weiss, Md Phd, MD PHD
Psychiatry — Payments: $44,312
Psychiatry $44,312
Duong Nguyen, M.d, M.D
Psychiatry — Payments: $12,734
Psychiatry $12,734
Dr. Richard Flanigin, M.d, M.D
Psychiatry — Payments: $7,211
Psychiatry $7,211